Rare Diseases
News from the FDA/CDC
FDA OKs first ustekinumab biosimilar
The drug has also been granted an interchangeability designation and has been approved for six indications.
News
FDA okays drug for Duchenne muscular dystrophy
The approval of vamorolone “provides people living with Duchenne, and their families, a powerful tool to treat the disease, while limiting some...
Commentary
Male patients with breast cancer: Special considerations and gender-specific concerns
Even the materials that we have are gender specific. I think those things all together can certainly contribute to a man feeling like a fish out...
Latest News
3-D stereophotogrammetry helps detect progression of craniofacial morphea
Existing tools that detect disease progression in patients with CM are limited.
News from the FDA/CDC
FDA approves first tocilizumab biosimilar
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
Latest News
Mohs found to confer survival benefit in localized Merkel cell carcinoma
Results provide “preliminary data suggesting that treatment of localized, early-stage MCC with MMS may result in the most optimal patient survival...
News from the FDA/CDC
FDA okays first-ever new drug for rare bone disorder
The drug reduced annualized heterotopic ossification volume by 54%.
Opinion
A 75-year-old White woman presented with diffuse erythema, scale, and pruritus on her scalp
The patient also had periorbital erythema, as well as erythema on the distal interphalangeal joints.
Latest News
West Nile infections rising in the U.S.
West Nile Virus is the leading cause of mosquito-borne disease in the continental United States.
Latest News
Study highlights diagnostic challenges of differentiating lichen sclerosus from vitiligo
The investigators aimed to characterize differences in LS and vitiligo based on history, physical exam, and demographic findings at the initial...
Latest News
Study evaluating in utero treatment for hypohidrotic ectodermal dysplasia seeks enrollees
Researchers are seeking to enroll mothers 18 years of age and older who are genetically confirmed carriers of the XLEHD mutation and pregnant with...